Skip to main content
Uni-Bio Science Group Limited logo

Uni-Bio Science Group Limited — Investor Relations & Filings

Ticker · 690 HKEX Manufacturing
Filings indexed 1,066 across all filing types
Latest filing 2015-05-08 Declaration of Voting R…
Country HK Hong Kong
Listing HKEX 690

About Uni-Bio Science Group Limited

http://www.uni-bioscience.com

Uni-Bio Science Group Limited is an innovative biopharmaceutical enterprise specializing in the R&D, manufacturing, and sales of biological and chemical pharmaceutical products. The company's core strategy centers on regenerative medicine, focusing on therapeutic areas such as endocrinology, dermatology, and ophthalmology. Key research pipelines address bone and muscle regeneration (including osteoporosis), skin and tissue repair (burns, chronic wounds, and medical aesthetics), and ocular regeneration (corneal damage and macular degeneration). Unique technological platforms include the ECO-KSFA® micro-protein manufacturing system for high-stability biologics and smart hydrogel technology for advanced tissue engineering and targeted delivery solutions.

Recent filings

Filing Released Lang Actions
POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON 8 MAY 2015
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is an announcement of the poll results from the Annual General Meeting (AGM) held on 8 May 2015. It details the voting outcomes on various resolutions including approval of financial statements, re-election of directors, re-appointment of auditors, and granting of general mandates. The text explicitly states it is the "POLL RESULTS OF THE ANNUAL GENERAL MEETING" and provides detailed voting percentages and shares. There is no full report or financial statements included, only the results of the shareholder votes. The document length is 4578 characters, which is relatively short and consistent with an announcement rather than a full report. Therefore, this document fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA).
2015-05-08 English
Next Day Disclosure Return
Share Issue/Capital Change Classification · 100% confidence The document is a Next Day Disclosure Return for a listed issuer, Uni-Bio Science Group Limited, reporting changes in issued share capital and share buybacks. It includes detailed information on share issues and repurchases pursuant to specific listing rules of The Stock Exchange of Hong Kong Limited. The content focuses on capital changes and share repurchase activities, with no financial statements or earnings data. This fits the definition of a Share Issue/Capital Change announcement rather than a full financial report or other categories.
2015-05-07 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 April 2015
Capital/Financing Update Classification · 95% confidence The document is titled 'Monthly Return of Equity Issuer on Movements in Securities' for the month ended 30 April 2015, submitted to the Hong Kong Exchanges and Clearing Limited. It details movements in authorised share capital, issued share capital, share options, warrants, convertibles, and other share-related transactions. The content focuses on changes in the company's capital structure and share issuance activities during the month. There are no financial statements, earnings data, management discussion, or audit information. The document is a regulatory filing reporting monthly share capital movements as required by the exchange. This type of document fits the category of Capital/Financing Update (CAP) as it provides updates on company fundraising, financing activities, or capital structure changes.
2015-05-04 English
VOLUNTARY ANNOUNCEMENT
Regulatory Filings Classification · 95% confidence The document is a voluntary announcement by Uni-Bio Science Group Limited regarding the filing and acceptance of a New Drug Application (NDA) by the China Food and Drug Administration (CFDA). It discusses the status of the drug application, clinical trial results, and potential market impact. The document is relatively short (3520 characters) and does not contain financial statements, detailed financial analysis, or regulatory certifications. It is an announcement of a significant corporate event related to product development and regulatory filing, not a financial report or management discussion. Therefore, it does not fit categories like Annual Report, Interim Report, or Earnings Release. It is also not a Board/Management change announcement or a voting result. The best fitting category is Regulatory Filings (RNS), which covers general regulatory announcements and miscellaneous filings that do not fit other specific categories.
2015-04-08 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 March 2015
Capital/Financing Update Classification · 95% confidence The document is titled 'Monthly Return of Equity Issuer on Movements in Securities' for the month ended 31 March 2015. It details movements in authorised share capital, issued share capital, share options, warrants, convertibles, and other share-related transactions. The content is focused on changes in the company's capital structure and share issuance activities. There is no indication of financial performance data, earnings, management discussion, or audit information. The document is a regulatory filing reporting monthly movements in securities for a listed issuer, which aligns with capital structure updates rather than a full financial report or earnings release. Therefore, the document fits best under the category of Capital/Financing Update (CAP). The document length is substantial (15,000 characters), indicating it is the report itself, not just an announcement of a report.
2015-04-08 English
NOTIFICATION LETTER AND REQUEST FORM
Report Publication Announcement Classification · 100% confidence The document is a notification letter dated 27 March 2015 from Uni-Bio Science Group Limited to non-registered shareholders. It informs recipients that the 2014 annual report for the nine months ended 31 December 2014 and a circular regarding general mandates to issue and repurchase shares, proposed re-election of directors, and notice of the annual general meeting are published on the company's website. The letter also includes a request form for shareholders to receive printed copies of these documents. The text explicitly states that the annual report and circular are available online and that this letter serves as a notification of their publication, not the reports themselves. The document is short (4949 characters) and does not contain the actual annual report or circular content but only announces their availability and provides instructions for obtaining printed copies. According to the "Menu vs Meal" rule, such a notification letter is classified as a Report Publication Announcement (RPA), not the Annual Report (10-K) or Circular itself.
2015-04-01 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.